 |
|
Takeda Pharmaceutical Company Limited |
| code | 4502Market
| TYO1, OSA1, NGO1, Fukuoka, SapCategory
of Business | Pharmaceuticals |
Inquiry : 12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668
[Official Homepage]
TEL : |
 |
Corporate Presentation |
 |
|
|
|
|
| First Quarter Financial Results for Fiscal 2008 |
|
|
|
|
|
General Manager, Corporate Strategy & Planning Dept. Masumitsu Inoue
General Manager, Strategic Product Planning Dept.Masato Iwasaki
General Manager, Finance & Accounting Dept.Hiroshi Takahara
General Manager, Corporate Communications Dept. M.C. Hirofumi Inoue |
|
|
|
|
|
|
|
|
|
| Key management policies for FY2008/Consolidated Results Summary for Fiscal 2007/Outlook for Consolidated Results for Fiscal 2008/R&D pipeline Update Fiscal 2007 |
|
|
|
|
|
Chairman of the Board Kunio Takeda
President Yasuchika Hasegawa
Corporate Officer, General Manager Finance & Accounting Department Hiroshi Takahara
General Manager Strategic Product Planning Dept. Masato Iwasaki
|
|
|
|
|
|
|
|
|
|
| Takeda Acquires Millennium Pharmaceuticals, Inc. |
|
|
|
|
|
President Yasuchika Hasegawa
|
|
|
|
|
|
|
|
|
|
| Restructuring of the U.S. Operations |
|
|
|
|
|
President Yasuchika Hasegawa
|
|
|
|
|
|
|
| Precautions in use |
 |
|
Nomura
IR assumes no responsibility for correctness, validity or
any other nature of the contents on this server.
No act such as alteration, modification or addition to the
contents is permitted.
Since the contents on this server are not intended to solicit
investment, our company has no liability for any trouble related
to investment made by any audience based on the contents of
this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity
or any other nature of information, including its format and
details, obtained from any site linked from our site. |
|
|
|
|
|
